Public spending on health care: How are different criteria related?

Health Policy

Volumn 47, Issue 3, 1999, Pages 207-223

  Musgrove, Philip ^a  

^a WORLD BANK   (United States)

Author keywords

Cost effectiveness; Criteria; Health care; Public expenditure

Indexed keywords

ARTICLE; COST BENEFIT ANALYSIS; ETHICS; HEALTH CARE FINANCING; HUMAN; PRODUCTIVITY; PUBLIC HEALTH SERVICE;

COST-BENEFIT ANALYSIS; DECISION MAKING, ORGANIZATIONAL; FINANCING, GOVERNMENT; HEALTH CARE RATIONING; HEALTH EXPENDITURES; HEALTH POLICY; HEALTH PRIORITIES; HEALTH SERVICES NEEDS AND DEMAND; NATIONAL HEALTH PROGRAMS; POVERTY; SOCIAL JUSTICE;

EID: 0033054088     PISSN: 01688510     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8510(99)00024-X     Document Type: Article

References (16)

1. Musgrave R.A. The Theory of Public Finance, A Study in Public Economy. 1959;McGraw-Hill, New York.
2. Musgrove P. Public and Private Roles in Health: Theory and Financing Patterns. World Bank Discussion Paper No. 339. 1996;The World Bank, Washington, DC.
3. Hammer J.S. Prices and protocols in public health care. World Bank Econ Rev. 11:1997.
4. Jamison D.T., Mosley W.H., Measham A.R., Bobadilla J.L. Disease Control Priorities in Developing Countries. 1993;Oxford University Press, Oxford.
5. World Development Report: Investing in Health. 1993;The World Bank, Washington, DC.
6. Gwatkin D.R., Guillot M. The burden of diseases among the global poor: current situation, future trends and implications for research and policy. 1998;The World Bank, Washington, DC. Prepared for the Global Forum on Health Research.
7. Beaton G.H., Martorell R., L'Abbé K.A., Edmonston B., McCabe G., Ross A.C., Harvey B. Effectiveness of Vitamin A Supplementation in the Control of Young Child Morbidity and Mortality in Developing Countries: Summary Report. 1993;University of Toronto, Toronto.
8. Bobadilla J.L., Cowley P., Musgrove P., Saxenian H. Design, content and financing of an essential national package of health services. Murray C.J.L., Lopez A Global Comparative Assessments in the Health Sector: Disease Burden, Expenditures and Intervention Packages. 1994;World Health Organization, Geneva.
9. Musgrove P. Cost-effectiveness and the socialization of health care. Health Policy. 32:1996;14.
10. Okun A.M. Equity and Efficiency: the Big Tradeoff. 1975;The Brookings Institution, Washington, DC.
11. Murray CJL. Rethinking DALYs. In [16] 1.
12. Goerdt A, Koplan JP, Robine JM, Thuriaux MC, van Ginneken KK. Non-fatal health outcomes. In [16] 99.
13. Annual Statistical Supplement, 1996, to the Social Security Bulletin. 1996;Social Security Administration, Washington, DC.
14. Eddy D.M. Oregon's methods: did cost-effectiveness analysis fail? J Am Med Assoc. 266:1996.
15. Hadorn D.C. Setting health care priorities in Oregon: cost-effectiveness meets the Rule of Rescue. J Am Med Assoc. 265:1996.
16. Murray C.J.L., Lopez A.D. The Global Burden of Disease. 1:1996;Harvard School of Public Health, Boston, MA. on behalf of the World Health Organization and the World Bank.